Worcester, MA, United States of America

Ivan Mascanfroni

This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignee: Seismic Therapeutic, Inc.. Active years: 2024.

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 7.2

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ivan Mascanfroni: Innovator in Protease Variants

Introduction

Ivan Mascanfroni is a notable inventor based in Worcester, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of protease variants. With a total of 2 patents to his name, Mascanfroni's work has the potential to impact various medical treatments.

Latest Patents

Mascanfroni's latest patents include "Protease variants and uses thereof" and "Fc fusion molecules and uses thereof." The first patent provides for polypeptides and molecules that comprise a polypeptide having protease activity and a variant Fc molecule. It also details pharmaceutical compositions that can be used to treat disorders, such as IgG mediated disorders. The second patent similarly focuses on polypeptides and molecules with protease activity and variant Fc molecules, emphasizing their pharmaceutical applications.

Career Highlights

Ivan Mascanfroni is currently associated with Seismic Therapeutic, Inc., where he continues to innovate in the field of biotechnology. His work is characterized by a commitment to developing solutions that address complex medical challenges.

Collaborations

Some of his notable coworkers include Jordan Anderson and Nathan Rollins. Their collaborative efforts contribute to the advancement of research and development in their field.

Conclusion

Ivan Mascanfroni stands out as an influential inventor in the biotechnology sector, with a focus on protease variants that hold promise for treating various disorders. His contributions are paving the way for future innovations in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…